Anatomical organization of excitatory amino acid receptors and their pathways
暂无分享,去创建一个
Carl W. Cotman | Ole P. Ottersen | C. Cotman | D. Monaghan | J. Storm-Mathisen | O. Ottersen | Jon Storm-Mathisen | Daniel T. Monaghan
[1] C. Cotman,et al. Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[2] P. Ascher,et al. Glycine potentiates the NMDA response in cultured mouse brain neurons , 1987, Nature.
[3] S. Halpain,et al. Quantitative autoradiography of binding sites for [3H]AMPA, a structural analogue of glutamic acid , 1984, Brain Research.
[4] C. Cotman,et al. [3H]CPP, a new competitive ligand for NMDA receptors. , 1986, European journal of pharmacology.
[5] S. Zukin,et al. Quantitative localization of [3H]TCP binding in rat brain by light microscopy autoradiography , 1985, Brain Research.
[6] C. D. Stern,et al. Handbook of Chemical Neuroanatomy Methods in Chemical Neuroanatomy. Edited by A. Bjorklund and T. Hokfelt. Elsevier, Amsterdam, 1983. Cloth bound, 548 pp. UK £140. (Volume 1 in the series). , 1986, Neurochemistry International.
[7] M. Kano,et al. Quisqualate receptors are specifically involved in cerebellar synaptic plasticity , 1987, Nature.
[8] D. Lodge,et al. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate , 1983, British journal of pharmacology.
[9] S. Snyder,et al. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. , 1986, The Journal of pharmacology and experimental therapeutics.
[10] P. Somogyi,et al. Quantification of immunogold labelling reveals enrichment of glutamate in mossy and parallel fibre terminals in cat cerebellum , 1986, Neuroscience.
[11] J. Wamsley,et al. Autoradiographic localization of high-affinity [3H]kainic acid binding sites in the rat forebrain. , 1983, European journal of pharmacology.
[12] T. Wieloch. Neurochemical correlates to selective neuronal vulnerability. , 1985, Progress in Brain Research.
[13] C. Cotman,et al. Anatomical distributions of four pharmacologically distinct 3H-L-glutamate binding sites , 1983, Nature.
[14] Joseph B. Martin,et al. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid , 1986, Nature.
[15] L. Iversen,et al. Uptake of [3H]glutamic acid in excitatory nerve endings: Light and electronmicroscopic observations in the hippocampal formation of the rat , 1979, Neuroscience.
[16] T. O'donohue,et al. Autoradiographic distribution of phencyclidine receptors in the rat brain using [3H]1-(1-(2-thienyl)cyclohexyl)piperidine ([3H]TCP) , 1986, Neuroscience Letters.
[17] N. Bowery,et al. Light microscopic autoradiographic localisation of [3H]glycine and [3H]strychnine binding sites in rat brain. , 1986, European journal of pharmacology.
[18] S. Naito,et al. Characterization of Glutamate Uptake into Synaptic Vesicles , 1985, Journal of neurochemistry.
[19] T. Stone,et al. Pharmacology and regional variations of quinolinic acid-evoked excitations in the rat central nervous system. , 1983, The Journal of pharmacology and experimental therapeutics.
[20] M. Lazdunski,et al. [3H]TCP: a new tool with high affinity for the PCP receptor in rat brain , 1983, Brain Research.
[21] T. Wieloch. Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. , 1985, Science.
[22] D. R. Curtis,et al. Chemical Excitation of Spinal Neurones , 1959, Nature.
[23] G. Fagg,et al. Amino acid neurotransmitters and their pathways in the mammalian central nervous system , 1983, Neuroscience.
[24] C. Cotman,et al. Autoradiography of d-2-[3H]amino-5-phosphonopentanoate binding sites in rat brain , 1984, Neuroscience Letters.
[25] C. Cotman,et al. Localization of N-acetylaspartylglutamate-like immunoreactivity in selected areas of the rat brain , 1986, Neuroscience Letters.
[26] J. Storm-Mathisen,et al. Glutamate : transmitter in the central nervous system , 1981 .
[27] J. Storm-Mathisen,et al. First visualization of glutamate and GABA in neurones by immunocytochemistry , 1983, Nature.
[28] C. Cotman,et al. Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells , 1978, Nature.
[29] A. Ganong,et al. Effects of excitatory amino acid antagonists on evoked and spontaneous excitatory potentials in guinea‐pig hippocampus. , 1986, The Journal of physiology.
[30] J. Storm-Mathisen,et al. Glutamate‐ and GABA‐containing neurons in the mouse and rat brain, as demonstrated with a new immunocytochemical technique , 1984, The Journal of comparative neurology.
[31] C. Cotman,et al. The distribution of [3H]kainic acid binding sites in rat CNS as determined by autoradiography , 1982, Brain Research.
[32] A. Ganong,et al. Long-term potentiation in the hippocampus involves activation of N-methyl-D-aspartate receptors , 1984, Brain Research.
[33] C. Cotman,et al. Long-term potentiation of guinea pig mossy fiber responses is not blocked by N-methyl d-aspartate antagonists , 1986, Neuroscience Letters.
[34] B. Meldrum,et al. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. , 1984, Science.
[35] C. Honey,et al. Ketamine and phencyclidine cause a voltage-dependent block of responses to l-aspartic acid , 1985, Neuroscience Letters.
[36] M. Cuénod,et al. In Vitro Release of Endogenous Excitatory Sulfur‐Containing Amino Acids from Various Rat Brain Regions , 1986, Journal of neurochemistry.
[37] J. Penney,et al. High correlation between the localization of [3H]TCP binding and NMDA receptors. , 1986, European journal of pharmacology.
[38] J. Storm-Mathisen,et al. Uptake of d-aspartate and l-glutamate in excitatory axon terminals in hippocampus: Autoradiographic and biochemical comparison with γ-aminobutyrate and other amino acids in normal rats and in rats with lesions , 1984, Neuroscience.
[39] C. Cotman,et al. Plasticity of hippocampal circuitry in Alzheimer's disease. , 1985, Science.
[40] C. Cotman,et al. [3H]TCP binding sites in Alzheimer's disease , 1987, Neuroscience Letters.
[41] J. Penney,et al. Dementia of the Alzheimer's Type: Changes in Hippocampal L‐[3H]Glutamate Binding , 1987, Journal of neurochemistry.
[42] J. Storm-Mathisen,et al. Different neuronal localization of aspartate-like and glutamate-like immunoreactivities in the hippocampus of rat, guinea-pig and senegalese baboon (Papio papio), with a note on the distribution of γ-aminobutyrate , 1985, Neuroscience.
[43] F. Fonnum. Glutamate: A Neurotransmitter in Mammalian Brain , 1984, Journal of neurochemistry.
[44] J. Penney,et al. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases. , 1985, Science.
[45] C. Cotman,et al. Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease , 1986, Brain Research.
[46] Malcolm M. Slaughter,et al. Excitatory amino acid receptors of the retina: diversity of subtypes and conductance mechanisms , 1986, Trends in Neurosciences.
[47] U. Heinemann,et al. Stimulus- and amino acid-induced calcium and potassium changes in rat neocortex. , 1985, Journal of neurophysiology.
[48] P. Streit. Selective retrograde labeling indicating the transmitter of neuronal pathways , 1980, The Journal of comparative neurology.
[49] C. Cotman,et al. Distribution of [3H]AMPA binding sites in rat brain as determined by quantitative autoradiography , 1984, Brain Research.
[50] A. Ganong,et al. Action of 3-((±)-2-car☐ypiperazin-4-yl)-propyl-1-phosphonic aci (CPP): a new and highly potent antagonist of N-methyl-d-aspartate receptors in the hippocampus , 1986, Brain Research.
[51] M. Williams,et al. Radioligand binding to central phencyclidine recognition sites is dependent on excitatory amino acid receptor agonists. , 1986, European journal of pharmacology.